Central Vascular Access Device Market Size, Share, Growth and Industry Analysis, By Type (PICC, Centrally Inserted Catheters, Implanted Ports, Other), By Application (Hospital, Non-Hospital), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

CENTRAL VASCULAR ACCESS DEVICE MARKET OVERVIEW

The global central vascular access device market size is forecasted to be worth USD 2.45 billion in 2025, expected to achieve USD 4.29 billion by 2034 with a CAGR of 6.46% during the forecast period from 2025 to 2034.

The United States Central Vascular Access Device market size is projected at USD 0.82 billion in 2025, the Europe Central Vascular Access Device market size is projected at USD 0.66 billion in 2025, and the China Central Vascular Access Device market size is projected at USD 0.63 billion in 2025.

The central vascular access device (CVAD) market continues to be driven by several key factors that collectively shape its dynamics. One primary driver is the increasing prevalence of chronic diseases globally. As conditions such as cancer, diabetes, and cardiovascular diseases become more prevalent, the demand for central vascular access devices rises, given their crucial role in facilitating the administration of prolonged and specialized treatments. This trend is further fueled by the aging global population, as elderly individuals are more susceptible to chronic illnesses, necessitating the use of CVADs for effective medical intervention.

Technological advancements play a pivotal role in the growth of the CVAD market. Ongoing innovations have led to the development of advanced devices with enhanced safety features, ease of use, and reduced complications. Manufacturers in the healthcare industry are investing significantly in research and development to introduce cutting-edge solutions that not only meet regulatory standards but also address the evolving needs of healthcare professionals and patients. This commitment to innovation is evident in the continual improvement of CVADs, contributing to their widespread adoption in both hospital and ambulatory care settings.

KEY FINDINGS

COVID-19 IMPACT

Market Growth Restrained by Pandemic due to Supply Chain Disruptions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

Lockdowns, travel restrictions, and increased demand for healthcare resources disrupted global supply chains, leading to temporary shortages and delays in the availability of CVADs and other medical devices. Many elective surgeries and non-urgent medical procedures, which may involve the use of CVADs, were postponed or canceled, impacting the overall demand for these devices during certain periods. The economic impact of the pandemic strained healthcare budgets, potentially influencing purchasing decisions and the adoption of new medical technologies, including CVADs. The pandemic posed challenges for ongoing research and development initiatives in the medical device industry, potentially delaying the introduction of new CVAD technologies to the market.

The surge in critically ill patients during the pandemic resulted in a heightened demand for central vascular access devices (CVADs) in intensive care units (ICUs) and critical care settings. The urgency of the healthcare crisis prompted an increased focus on innovation in medical technologies, including CVADs. This could lead to the development of more advanced and efficient devices.

LATEST TRENDS

Miniaturization and Integration in CVADs to Drive Market Growth

Imagine CVADs not just monitoring basic readings, but also detecting early signs of infection, medication reactions, or even blood clots through advanced sensors. This allows for proactive measures and the development of personalized care strategies. Real-time data transmission via IoT allows medical professionals to remotely track a patient's progress, reducing hospital visits and improving convenience, especially for home-based care. Think Lego blocks for CVADs! Standardized modules like ports, catheters, and extension lines can be combined and customized to match specific patient needs and treatment durations. These advancements in miniaturization and integration are transforming the CVAD market, revolutionizing patient care, and pushing the boundaries of what's possible in vascular access technology. By embracing these trends and developing innovative solutions, manufacturers can contribute to a future where personalized, data-driven, and minimally invasive care becomes the norm for CVAD patients.

• As per healthcare utilization trends observed in developed nations, more than 65% of ICU patients now receive multi-lumen central lines for administering simultaneous therapies. A typical triple-lumen catheter setup reduces line-change frequency by 32%, enhancing workflow efficiency.

• Clinical guidelines suggest that 1 in every 3 central vascular procedures in outpatient oncology centers now uses PICCs. These catheters are linked with a 25% lower risk of bloodstream infections compared to tunneled alternatives, supporting their expanding adoption.

Request a Free sample to learn more about this report

CENTRAL VASCULAR ACCESS DEVICE MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into PICC, centrally inserted catheters, implanted ports, & others.

• PICC: A long, thin tube inserted through a vein in the arm, extending to the larger veins near the heart, commonly used for long-term intravenous treatments.

• Centrally Inserted Catheters: Catheters inserted into a large central vein, such as the subclavian or jugular vein, facilitate rapid and sustained access to administering medications, fluids, or other treatments.

• Implanted Ports: Subcutaneously implanted devices with a reservoir connected to a catheter, providing a discreet and long-term central access point for medical treatments, reducing the risk of infection.

• Other: This category encompasses various devices, including tunneled catheters, hemodialysis catheters, and non-tunneled central catheters, each designed for specific medical needs, procedures, or durations of use.

By Application

Based on application the global market can be categorized into hospital, non-hospital.

• Hospital: Dominated by the use of central vascular access devices in hospital settings, including ICUs and surgical units, driven by the need for critical care and specialized medical interventions.

• Non-Hospital: Encompasses various healthcare settings outside traditional hospitals, such as ambulatory care centers, home healthcare, and long-term care facilities, reflecting the growing trend towards decentralized and patient-centric healthcare solutions.

DRIVING FACTORS

Increasing Aging Population and Technological Advancements to Boost the Market

One of the key driving factors in the global central vascular access device market growth is the increasing aging population and technological advancements in urban areas. The rising incidence of chronic conditions, such as cancer, diabetes, and cardiovascular diseases, necessitates long-term medical interventions, driving the demand for CVADs for the administration of medications and therapies. The global demographic shift towards an aging population contributes to a higher prevalence of diseases requiring ongoing treatment, spurring the demand for CVADs to facilitate efficient and sustained delivery of medical interventions.

Increasing Awareness and Surgical Procedures to Expand the Market

Another driving factor in the global central vascular access device market is the awareness and surgical procedures offered by these products. Increased awareness among healthcare professionals about the benefits of using CVADs, coupled with ongoing education and training programs, enhances the proper utilization of these devices, contributing to market growth. The growth in surgical interventions, both elective and non-elective, leads to a greater need for CVADs for various medical applications, including anesthesia, nutrition, and postoperative care. The use of CVADs in critical care settings, such as intensive care units (ICUs) and emergency departments, is essential for the rapid and precise administration of medications and fluids to critically ill patients.

• According to national health data tracking chronic conditions, over 42 million patients annually worldwide require central vascular access for chemotherapy, total parenteral nutrition, or dialysis. This has contributed to an 18% year-over-year increase in catheter placements in hospitals.

• Emergency medical response guidelines show that above 70% of trauma patients transported to tertiary hospitals require immediate vascular access. Central access devices enable fluid administration rates of up to 250 mL/min, critical for hemorrhage or shock management.

RESTRAINING FACTORS

High Cost and Risk of Infections to Potentially Impede Market Growth

One of the key restraining factors in the global central vascular access device market is the high cost and risk of infections of these products. The cost of acquiring and maintaining CVADs, along with the expenses related to insertion procedures and necessary follow-up care, may pose financial challenges for healthcare facilities and limit their widespread adoption. CVADs are associated with a risk of infections, including catheter-related bloodstream infections (CRBSIs), which can hinder their widespread use due to concerns about patient safety and healthcare-associated infections. Complications such as thrombosis, malpositioning, and mechanical failures can occur with CVADs, leading to adverse events that may discourage healthcare providers from using these devices.

• Clinical safety audits report a CRBSI incidence of 0.5–2.7 cases per 1,000 catheter days, leading to prolonged hospitalization and added treatment costs of USD 3,700–29,000 per case. This has made hospital administrators cautious about unnecessary central line insertions.

• Insertion success rates drop by 15–20% in pediatric and elderly patients due to narrower veins and comorbidities, necessitating advanced imaging or surgical expertise. In many rural hospitals, only 40% of providers have routine access to ultrasound-guided insertion technology.

• Request a Free sample to learn more about this report

•  

CENTRAL VASCULAR ACCESS DEVICE MARKET REGIONAL INSIGHTS

North America Region Dominating the Market due to Presence of a Large Consumer Base

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America has emerged as the most dominant region in the global central vascular access device market share due to several factors. The North American region, comprising the United States and Canada, has traditionally been a significant player in the medical device market. The presence of advanced healthcare infrastructure, high healthcare expenditure, a well-established regulatory framework, and a large patient population contribute to the region's prominence in the CVAD market. The region's aging population and the prevalence of chronic diseases contribute to the demand for CVADs. Additionally, the North American regulatory environment ensures product safety and efficacy. Increasing healthcare investments, a growing population, and a rising prevalence of chronic diseases contribute to the expanding market for CVADs in this region. The demand for advanced medical devices, including CVADs, is likely to increase as these countries develop economically. In this region, the demand for medical devices is growing, driven by efforts to improve healthcare access and address the burden of diseases.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market through Innovation and Market Expansion

The central vascular access device (CVAD) market is significantly influenced by key industry players that play a crucial role in shaping market dynamics and meeting healthcare professionals' preferences. These key players possess extensive distribution networks and online platforms, providing healthcare facilities with convenient access to a diverse range of CVAD options. Their robust global presence and brand recognition have fostered increased trust among healthcare providers, influencing the widespread adoption of these devices. Furthermore, these industry leaders consistently invest in research and development, introducing innovative designs, materials, and advanced features in CVADs to address evolving healthcare needs and preferences. The collaborative efforts of these major players significantly impact the competitive landscape and future trajectory of the CVAD market.

• Edwards Lifesciences Corporation: Edwards Lifesciences delivers vascular access solutions used in over 75 countries, with their Swan-Ganz catheter adopted in over 1.2 million critical care cases annually. Their devices feature hemodynamic monitoring with an accuracy variance under ±5%, aiding real-time patient management.

• B. Braun: B. Braun supports vascular access needs in more than 3,000 hospitals globally, with its Certofix® line designed for up to 29-day dwell times. Each catheter kit includes antimicrobial coatings proven to reduce infection risk by up to 40%, as validated in hospital infection control trials.

List of Top Central Vascular Access Device Companies

• Edwards Lifesciences Corporation
• B.Braun
• Smiths Medical, Inc
• AngioDynamics
• Becton Dickinson
• Teleflex Incorporated
• Vygon Ltd.
• C. R. Bard, Inc.
• Ameco Medical
• NIPRO Medical Corporation
• Terumo Corporation
• PRODIMED
• Romsons

INDUSTRIAL DEVELOPMENT

November 2023: Abbott launched FreeStyle Libre 3, a CVAD system with an integrated sensor offering continuous glucose monitoring, reducing finger pricking, and improving diabetes management.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.